HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67.

Abstract
Cholesteatoma epithelium is characterized by a keratinocyte dysregulation with aggressive growth subsequently destroying the middle ear mucosa. The monoclonal antibody Ki-67 recognizes a nuclear antigen expressed by cells in the G1, S, and G2/M phases being used to determine the growing cell fraction in tissue samples. Cryostat sections of skin and cholesteatoma biopsies were examined immunohistochemically for reactivity with Ki-67 using the alkaline phosphatase-anti-alkaline phosphatase method. Nuclear staining was seen in a small number of keratinocytes located in the basal cell layer of normal auditory meatal skin. In contrast, numerous cells of the basal and suprabasal layers in cholesteatoma were found to react with Ki-67. A cytoplasmic staining was also observed in both skin and cholesteatoma. In cholesteatoma, the cytoplasmic staining was stronger. These results clearly show that cholesteatoma epithelium proliferates at a higher rate than normal epidermis, confirming the hyperproliferative behavior of cholesteatoma.
AuthorsJ Bujia, A Holly, H Sudhoff, F Antoli-Candela, M G Tapia, E Kastenbauer
JournalORL; journal for oto-rhino-laryngology and its related specialties (ORL J Otorhinolaryngol Relat Spec) 1996 Jan-Feb Vol. 58 Issue 1 Pg. 23-6 ISSN: 0301-1569 [Print] Switzerland
PMID8718533 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Coloring Agents
Topics
  • Antibodies, Monoclonal
  • Cell Division
  • Cholesteatoma, Middle Ear (pathology)
  • Coloring Agents
  • Humans
  • Immunohistochemistry
  • Keratinocytes (cytology, pathology)
  • Skin (cytology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: